This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.F Zepp , Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infectious Diseases 2011; 11: 557–570.
3.J Cherry . Epidemic pertussis in 2012 – the resurgence of a vaccine-preventable disease. New England Journal of Medicine 2012; 367: 785–787.
The changing age and seasonal profile of pertussis in Canada. Journal of Infection
2002; 185: 1696.
5.J Torres , Outbreak of whooping cough with a high attack rate in well-vaccinated children and adolescents. Enfermedades Infecciosas y Microbiología Clínica 2011; 29: 564–567.
6.HE Melker , Re-emergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerging Infectious Diseases 2000; 6: 348–357.
Outbreak of pertussis in a fully immunized adolescent and adult population. Clinical Infectious Diseases
1992; 14: 464–471.
8.World Health Organization. Pertussis surveillance, a global meeting, Geneva, 16–18 October 2000 (2001). Departments of Vaccines and Biologicals. Geneva: World Health Organization, WHO/V&B/01.19.
10.W Yih , The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998. Journal of Infectious Diseases 2000; 182: 1409–16.
. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatric Infectious Disease
2005; 24: 721–728.
12.World Health Organization. Immunization profile – China, 2010.
13.Z Qi , The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infectious Diseases 2012; 12: 138.
15.J Fu , Analysis on pertussis epidemiology in Zhejiang province in 1954–2004. Chinese Journal of Vaccines and Immunization 2005; 11: 279–281.
19.HO Hallander , Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with bordetella pertussis in young children. APMIS 2009; 117: 797–807.
23.H Hallander , Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS 2009; 117: 912–922.
24.JD Cherry , Defining pertussis epidemiology, clinical, microbiologic and serologic perspectives. Pediatric Infectious Disease Journal 2005; 24: s25–s34.